Cytokinetics, Incorporated company logo
Cytokinetics, Incorporated logo

Cytokinetics, Incorporated (CYTK) EBITDA

Annual EBITDA

-$602.13M$75.42M-14.32%

Summary

Current Value
As of today, CYTK annual EBITDA is -$602.13M, down -14.32% on
Historical Performance
CYTK annual EBITDA is down -90.67% over the past 3 years, down -553.70% over the past 5 years
All-Time High Comparison
CYTK annual EBITDA is currently -2243.36% below its historical high of $28.09M set on
3-Year Low Comparison
CYTK annual EBITDA is at its 3-year low
Sector Comparison
CYTK annual EBITDA is higher than 1.11% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

CYTK Performance
MetricDateValue1Y3Y5Y15Y
-$602.13M-14.3%-90.7%-553.7%-1161.4%
-$175.51M-28.4%-41.2%-388.4%-1471.2%
-$602.13M-14.3%-90.7%-553.7%-1161.4%
Price$64.94+80.4%+78.3%+178.2%+641.3%
-
$88.04M+376.6%-6.9%+57.7%+3316.3%
-$6.54-24.1%-50.9%-231.3%-41.5%
-$612.26M-14.2%-88.8%-551.7%-1133.5%
-$784.96M-33.1%-101.8%-516.7%-1492.6%

EBITDA Highs

CYTK Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y-$315.80MN/A-90.7%
5Y-$92.11MN/A-553.7%
All$28.09M-2243.4%

EBITDA Lows

CYTK Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$602.13Mat low
5Y-$602.13Mat low
All-$602.13Mat low

EBITDA History

YearValueChange
-$602.13M-14.3%
-$526.72M-8.8%
-$484.31M-53.4%
-$315.80M-78.7%
-$176.68M-91.8%
-$92.11M+5.6%
-$97.57M-11.3%
-$87.68M+21.4%
-$111.50M-846.9%
$14.93M+140.5%
-$36.82M-158.1%
-$14.26M+57.4%
-$33.46M+16.2%
YearValueChange
-$39.92M+12.2%
-$45.48M+4.7%
-$47.74M-269.9%
$28.09M+151.9%
-$54.15M-0.9%
-$53.66M+8.1%
-$58.41M-40.5%
-$41.57M-18.2%
-$35.16M-19.5%
-$29.41M-39.2%
-$21.13M-26.0%
-$16.78M-29.7%
-$12.93M-

FAQ

  • What is the current annual EBITDA of CYTK?

    As of today, CYTK annual EBITDA is -$602.13M

  • What is 1-year change in CYTK annual EBITDA?

    CYTK annual EBITDA is down -14.32% year-over-year

  • What is 3-year change in CYTK annual EBITDA?

    CYTK annual EBITDA is down -90.67% over the past 3 years

  • How far is CYTK annual EBITDA from its all-time high?

    CYTK annual EBITDA is currently -2243.36% below its historical high of $28.09M set on December 31, 2009

  • How does CYTK annual EBITDA rank versus sector peers?

    CYTK annual EBITDA is higher than 1.11% of companies in Healthcare sector

  • When is CYTK next annual earnings release?

    As of today, the next annual earnings release for CYTK has not been scheduled

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. CYTK Official Website www.cytokinetics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
  4. CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
  5. CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk